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Abstract
A subset of patients with monogenic disorders lacks disease causing mutations in the pro-
tein coding region of the corresponding gene. Here we describe a recurrent germline muta-
tion found in two unrelated patients with complete androgen insensitivity syndrome (CAIS)
generating an upstream open reading frame (uORF) in the 5’ untranslated region (5’-UTR)
of the androgen receptor (AR) gene. We show in patient derived primary genital skin fibro-
blasts as well as in cell-based reporter assays that this mutation severely impacts AR func-
tion by reducing AR protein levels without affecting ARmRNA levels. Importantly, the newly
generated uORF translates into a polypeptide and the expression level of this polypeptide
inversely correlates with protein translation from the primary ORF of the AR thereby provid-
ing a model for AR-50UTRmediated translational repression. Our findings not only add a
hitherto unrecognized genetic cause to complete androgen insensitivity but also underline
the importance of 50UTR mutations affecting uORFs for the pathogenesis of monogenic dis-
orders in general.
Introduction
Post-transcriptional control of gene expression is considered an important mechanism for cells
to quickly respond to internal and external stimuli. The untranslated regions (UTRs) at both
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ends of an mRNA play thereby an important role. While the 30UTR has been extensively stud-
ied as a major place of regulation e.g. through microRNA mediated mRNA degradation and
translational inhibition [1], translational regulation through the 50UTR is a field that more
recently came into focus. 50UTRs are the sites where ribosomes enter and scan the mRNA for a
suitable translational start codon at which the translation initiation complex becomes assem-
bled. This scanning can be influenced by secondary structures of the mRNA as well as the pres-
ence of upstream open reading frames [2]. The latter are cis-regulatory sequences in the 5’-
UTR of eukaryotic mRNAs defined by a start codon and an in frame stop codon, located either
upstream of or overlapping with the main initiation codon of the gene. uORFs can reduce
translation of the downstream encoded protein by hindering ribosome progression or seques-
tering functional pre-initiation complexes [3]. uORF mediated post-transcriptional regulation
of gene expression has been associated with stress response and mutations changing the uORF
have been implicated in the etiology of human diseases [3–6].
The 50UTR of the androgen receptor has several features characteristic for translational reg-
ulation: its 1,115 nucleotides (nt) largely exceed the typical length of 100–220 nt across species
and it is GC rich, thus prone to secondary structures. The AR belongs to the nuclear receptor
superfamily of transcription factors. It is activated by its ligand dihydrotestosterone (DHT)
which induces a conformational change of the AR and its translocation into the nucleus.
Uncontrolled high AR-activity can lead to prostate cancer [7]. Too low AR-activity on the
other hand can cause the monogenic condition androgen insensitivity syndrome (AIS), defined
by the inability of the androgen receptor to properly respond to androgens i.e. DHT [8]. AR-
activity is essential for male sex development and individuals with AIS although having a male
chromosome set and normal male serum testosterone levels develop with a partial or complete
female phenotype. AIS is a common cause of disorders of sex development (DSD) and can be
divided in three major subgroups: complete AIS (CAIS) with no residual AR-function charac-
terized by female external genitalia, partial AIS (PAIS) with a variably impaired AR causing
incomplete virilisation, and mild AIS (MAIS) presenting with normal male external genitalia
but infertility [9, 10]. In over 85% of cases, CAIS is explained by loss of function mutations
affecting the coding region of the AR gene, while this applies only to roughly one-third of PAIS
cases [11, 12].
Androgen signaling has been extensively studied mainly in prostate cancer. Comparatively
little is known about the regulation of ARmRNA stability and translation. In 1994, Mizokami
et al. [13] showed, using reporter assays, that parts of the AR-50UTR are essential for induction
of translation but not transcription. They hypothesized that mutations in the 50UTR of the AR
could be one of the reasons for androgen insensitivity due to reduced AR translation without
affecting AR mRNA levels. However, up to now, no such mutation has been described.
Here we present two unrelated 46,XY girls diagnosed with CAIS but lacking mutations in
the coding region of the AR. Genomic next generation sequencing (NGS) of the complete AR
locus revealed the same c.-547C>T germline mutation in the AR-5’-UTR of both patients. We
show both in vitro and in vivo that this mutation introduces a translated uORF in the 50UTR of
the AR and results in a reduced AR protein expression without affecting ARmRNA
accumulation.
Results
Two individuals presenting with complete androgen insensitivity but
lacking mutations within the coding region of the AR
Patient 1 was born at term with female external genitalia. At the age of two weeks, an inguinal
hernia on the left side was detected. Ultrasound examination suggested a testis within this
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hernia and a second testis at the internal orifice on the right. Lack of a uterus in combination
with a blind ending vagina was detected and confirmed during surgical exploration. Chromo-
somal analysis revealed a 46,XY karyotype. Laboratory testing showed a massively elevated
plasma testosterone concentration of 1,065 ng/dL (normal male range 14–363 ng/dL) together
with an LH level of 2.2 IU/L (normal male range<0.3–2.5 IU/L). Therefore, the phenotype of
the patient and the hormonal picture indicated the clinical diagnosis of CAIS. However, subse-
quent Sanger sequencing of the complete AR coding gene region including the intron-exon
boundaries did not reveal any mutation. Further laboratory data are listed in Table 1.
Patient 2 was a term newborn with female external genitalia. In the second year of life, ingui-
nal hernias occurred at both sides and were surgically repaired. At the age of six years, due to
tomboyish behavior the mother insisted on chromosome analysis revealing a 46,XY karyotype.
Subsequently the patient was transferred to a Pediatric Endocrinology Center. An hCG test
(5,000 IU hCG/m2 i.m., once) was performed and indicated normal Leydig cell function with a
rise of testosterone from 28 ng/dL to 238 ng/dL after 72 h. Surgical exploration confirmed the
absence of a uterus and ovaries. Histology of gonadal biopsies showed immature testicular tissue
with strong immunohistochemical expression of α1-inhibin. Therefore, the patient’s phenotype
in conjunction with the laboratory data indicated the clinical diagnosis CAIS. However, no
mutation was detected in the AR coding gene region including the intron-exon boundaries.
During her most recent visit at the age of 13.6 years, she presented with a breast Tanner stage
B4 and a plasma estradiol concentration of 18.9 ng/L (normal for B3 in 46,XX girls). No clinical
signs of virilisation, i.e. clitoromegaly, were present despite a very high plasma testosterone of
693ng/dL (upper male range). Further laboratory data are listed in Table 2.
Identification of a 50UTRmutation in the AR in both patients
We hypothesized that the CAIS-phenotype of the two patients could be due to a mutation in
regulatory regions of the AR gene that usually escape routine Sanger sequencing. We therefore
used an NGS approach to sequence the entire AR genomic locus in the two patients0 genital skin
fibroblasts (GF) including the promoter, untranslated regions and the introns. In line with rou-
tine Sanger sequencing, NGS did neither reveal mutations in the AR coding sequence nor in the
intron-exon boundaries. Instead, analysis for single nucleotide polymorphisms (SNP) and small
insertion deletions (indels) of the NGS-data showed a hemizygous C to T mutation in both
patients located in the 50UTR of the ARmRNA (c.-547C>T; NM_000044.3; hg19) (Fig 1A and
1B, S1 and S2 Files). In order to exclude that the patients are related, we checked the SNP
Table 1. Additional data on index patient 1.
Analysis performed findings
sequencing of the AR gene no mutation within coding sequence (CDS) and intron/exon
boundaries
sequencing of the SRD5A2 gene no mutation within CDS and intron/exon boundaries
sequencing of the NR5A1 gene no mutation within CDS and intron/exon boundaries
sequencing of the HSB17B3 gene no mutation within CDS and intron/exon boundaries
array-CGH unsuspicious
gonadal histology after gonadectomy (2.75
years)
immature tubuli seminiferi
TSPY+ germ cells in about 50% of the tubuli
rare OCT3/4+ germ cells
rare Sertoli cells, rare Leydig cells
interstitial edema
doi:10.1371/journal.pone.0154158.t001
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distribution in the analyzed region as well as the length of the polyglutamine repeat present in
exon 1 which is located only 716 base pairs downstream the c.-547C>T mutation. SNP analysis
revealed two different haplotypes (S1 and S2 Files). Furthermore the polyglutamine stretch in
patient 1 consists of 24 glutamines compared to 19 glutamines in patient 2 indicating that the
patients are indeed not related. We subsequently screened GF derived genomic DNA from
Table 2. Additional data on index patient 2.
Analysis performed findings
sequencing of the AR gene no mutation within CDS and intron/exon boundaries
sequencing of the NR5A1 gene no mutation within CDS and intron/exon boundaries
sequencing of the HSB17B3 gene no mutation within CDS and intron/exon boundaries
hCG test (8.75 years) 5.000 IU hCG/m2 i.m: testosterone rise from 28 ng/dL to 238 ng/dL;
DHT rise from 8ng/dL to 33ng/dL
testosterone / dihydrotestosterone ratio 7.21 (normal)
Gonadal histology after
orchidopexy (7.66 years)
strong immunohistochemical expression of a1-inhibin
12.5 years LH: 26.33 IU/L
doi:10.1371/journal.pone.0154158.t002
Fig 1. Next generation sequencing of the AR in the two index patients. A) Schematic representation of
the AR-50UTRs and CDS. The position of the c.-547C>T mutation and the uORF are indicated. B) A Haloplex
library spanning the coding region, introns, UTRs and up and downstream sequences of the AR genomic
locus was prepared from DNA of the index patients0 GF and sequenced on a MiSeq benchtop sequencer.
Analysis for single nucleotide polymorphisms (SNP) and small insertion deletions (indels) was performed by
the SureCall software (Agilent). Indicated is the mutation found in the 50UTR of the AR. A frequency of 1
corresponds to 100% of the reads. The depth indicates the number of reads covering the indicated genomic
position. C) Sanger sequencing of a male control and the index patients 1 and 2. The sequences are
visualized as reverse complement strand using the Chromas Lite software and show the c.-547C>T mutation
in both index patients but not in the male control. D) Sanger sequencing of blood derived DNA from both
index patients as well as from the mothers of the index patients. The sequences are visualized as reverse
complement strand using the Chromas Lite software and show the c.-547C>T mutation in both index patients
and in the patients0 mothers in a heterozygous constellation.
doi:10.1371/journal.pone.0154158.g001
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further 25 foreskin controls without detecting the c.-547C>Tmutation which was also absent
in publicly available SNP databases including dbSNP and the 1000 Genome Project (hg19;
release 68) The presence of the mutation was confirmed by Sanger sequencing in GF (Fig 1C) as
well as peripheral blood of both patients indicating that the mutation is of germline rather than
somatic origin. Consistently, the mutation was detected in a heterozygous constellation in the
mothers of both patients (Fig 1D).
Context analysis of the mutation showed that the c.-547C>T mutation creates a transla-
tional initiation codon ATG imbedded in a vertebrate Kozak sequence (S1 Fig) [14]. 183 nucle-
otides downstream of the ATG are two consecutive Stop-codons thereby delineating a short
uORF within the AR-50UTR schematically depicted in Fig 1A.
Functional analysis of the AR-50UTRmutation in vitro
In order to functionally characterize the impact of the identified mutation, we cloned the entire
50UTR of either the wild type (wt) or the mutated (mut) AR directly upstream of a green fluo-
rescent protein (GFP) reporter gene and transfected the fusion constructs in HEK293 cells.
Importantly, the newly generated uORF is out of frame with the primary ORF (pORF) of the
AR as well as of the GFP in the AR50UTR-GFP vector and therefore cannot create an AR-
uORF-GFP fusion protein. Transcript analysis of the GFP reporter showed no difference in
mRNA accumulation levels between the wild type and mutant AR50UTR-GFP fusion construct
(Fig 2A). In order to exclude a possible GFP-amplification from plasmid DNA during the RNA
quantification, we included a control without reverse transcription which showed no amplifica-
tion product underlining the specificity of the GFPmRNAmeasurement (S2 Fig). In contrast
to comparable GFPmRNA levels, GFP detection by Western blot showed a reduced GFP pro-
tein expression of the mutant AR50UTR-GFP construct as compared to the wild type construct
(Fig 2B). We also performed fluorescence activated cell sorting (FACS) analysis in order to
compare the fluorescent intensity between the wild type and the mutant construct on a single
cell basis. This revealed a lower GFP signal intensity in cells transfected with the mutant
AR50UTR-GFP vector as compared to wild type transfected cells (Fig 2C). Therefore, we show
in two independent approaches that the mutation in the AR-50UTR identified in both patients
is causative for the reduced GFP protein level.
We then wanted to investigate, if the mutation in the 50UTR also reduces AR-protein func-
tion in vitro.
To this aim we cloned both wild type and mutant 5`UTR in front of the AR-CDS and trans-
fected the corresponding plasmids into AR-negative HEK293 cells together with a plasmid
containing an androgen response element (ARE) in front of a luciferase reporter gene. Firefly
luciferase measurements were normalized for transfection efficiency by co-measuring Renilla
luciferase expression. Cells transfected with the AR50UTRwt-AR construct showed a mean 5.7
fold induction of AR mediated luciferase expression while this induction was strongly reduced
in cells transfected with the AR50UTRmut-AR plasmid (Fig 2D). This proves that the mutation
in the AR50UTR is responsible for a reduced transcriptional activity of the AR protein.
Expression analysis of wildtype and mutated AR in vivo and in vitro
The results described suggest that in patients carrying the mutation in the 50UTR, AR function
might be reduced due to reduced post-transcriptional AR protein expression. We therefore
sought to analyze AR expression levels in GFs from the patients compared to a male control.
Although we obtained GF of documented labial origin from the first patient, the second
patient0s GF were taken from the inguinal region outside the genitalia which is not a classical
androgen responsive tissue. We thus used only GF from patient 1. When analyzing ARmRNA
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expression no significant difference was seen between control GF and the patient0s GF (Fig
3A). At the protein level instead, the patient0s GF showed a strong reduction of the full-length
AR protein. At the same time, a lower migrating band of approximately 75kD was increased in
the patient0s GF compared to control GF (Fig 3B). Dihydrotestosterone (DHT) is known to
activate and stabilize full length AR once it is released from the chaperones by N/C-terminal
protein interaction [15]. Consistently, we found an increase of the full-length AR protein upon
DHT treatment in GF from the male control and the index patient, but not of the shorter AR-
fragment (Fig 3B). GF-derived protein extracts from a CAIS patient with a known AR-frame-
shift mutation [16] and a complete loss of AR expression served as negative control (Fig 3B).
In order to recapitulate the AR protein expression pattern in vitro, we transfected above
described plasmids containing wild type and mutant 5`UTR in front of the AR-CDS into AR-
depleted prostate cancer PC3 cells. We chose PC3 cells because prostate is an androgen respon-
sive tissue and response to DHT treatment can be monitored. Indeed, AR50UTRwt-AR
Fig 2. The c.-547C>Tmutation in the AR-50UTR reduces translation and AR activity in vitro. HEK293 cells were transfected with either empty vector,
AR50UTRwt-GFP or AR50UTRmut-GFP. After 72h of transfection RNA and protein was isolated. A) Q-RT-PCR analysis of GFPmRNA. There is no significant
difference betweenGFPmRNA levels of the AR50UTRwt-GFP and the AR50UTRmut-GFP construct (p = 0.57).GFPmRNA levels were normalized to the
neomycin resistance (neo) expression of the vector. Experiments were performed in triplicate. B) GFP protein analysis. Cells transfected with the
AR50UTRmut-GFP construct show a reduced expression of the GFP protein compared to the wt-construct. GAPDHmeasurement served as loading control.
The experiment was done in triplicate. One representative blot is displayed. C) FACS analysis of AR50UTR-GFP transfected cells. FACS analysis was
performed equally 72h after transfection. Cells transfected with AR50UTRmut-GFP show less fluorescent intensity. D) Transcriptional activity of AR50UTRwt-
AR and AR50UTRmut-AR. HEK293 cells were transfected with either empty vector, AR50UTRwt-AR or AR50UTRmut-AR. After 48h of transfection luciferase
activity was measured. AR induced luciferase expression is significantly lower in AR50UTRmut-AR transfected cells in respect to AR50UTRwt-AR transfected
cells (p***<0.001).
doi:10.1371/journal.pone.0154158.g002
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Fig 3. Functional and expression analysis of the AR in vivo and in vitro. A) ARmRNA accumulation in GF. Total RNA was extracted from GF of a male
control, a CAIS patient with a documented frameshift mutation in the AR gene and index patient 1. Means and standard deviations of three independent
experiments are shown. B) DHT-dependent AR protein expression in GF. Whole cell protein lysates were extracted from GF of the male control, the index
patient and the CAIS patient with a documented frameshift mutation and treated with 10nM DHT or ethanol, respectively. From all samples, 35 μg of protein
were loaded, additionally 10 μg were loaded for the control sample to avoid overexposition. Immunoblot analysis shows a markedly reduced amount of the
112 kD full-length AR protein in the index patient and an increased detection of a shorter 75kD fragment. DHT treatment stabilizes full-length 112kD AR
protein while the shorter 75kD fragment remains of similar intensity as compared to untreated GF. The corresponding bands are indicated by an arrow. An
unspecific band is denoted by a star. GF from the CAIS patient served as negative control. Actin measurement served as loading control. C) DHT-dependent
ectopic AR protein expression in PC3 cells. Cells were either treated with 10nM DHT or ethanol. 50UTRmut-AR transfected cells show reduced AR protein
expression compared to 50UTRwt-AR transfected cells. AR-121 transfected cells express an AR-fragment of lower molecular weight. Actin measurement
served as loading control. D) DHT-dependent activation of the AR target gene APOD is compromised in the index patient. AR activity was measured through
the activation of the endogenous AR target gene APOD. This revealed a mean 3.4 fold activation of APOD in response to DHT stimulation in three male
foreskin control derived cell lines. GF of the index patient, like GF of the CAIS patient with knownmutation show a highly significant loss of APOD induction as
compared to the male controls (p***<0.001). Means and standard deviations of three independent experiments are shown. p-values are calculated by a t-
test. E) DHT-dependent activation of the AR target gene PPAP2B is compromised in the index patient. AR activity was measured through the activation of the
endogenous AR target gene PPAP2B. This revealed a mean 1.54 fold activation of PPAP2B in response to DHT stimulation in three male foreskin control
derived cell lines. GF of the index patient, like GF of the CAIS patient with known mutation show a significant loss of PPAP2B induction as compared to the
male controls (p**<0.01). Means and standard deviations of at least three independent experiments are shown. p-values are calculated by a t-test.
doi:10.1371/journal.pone.0154158.g003
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transfected PC3 cells showed an enhanced AR-protein signal after DHT treatment as com-
pared to untreated cells, indicating that the construct readily responds to androgens (Fig 3C).
When looking at the AR50UTRmut-AR construct, AR-expression levels were strongly reduced
but still responsive to DHT treatment reflecting the situation in GF from patient 1 (Fig 3C). A
lower molecular weight band also appears in the mutant, although at a different ratio in respect
to the full length AR protein observed in vivo. We speculated that the lower band could be
another translational start as initiation of translation at the next downstream ATG within the
AR-CDS at amino acid 191 has been proposed in the literature and an AR-plasmid starting at
this second ATG (AR-121) has been designed previously [17]. The calculated molecular weight
of this shorter AR fragment would be 78kD. When analyzing cell extracts of PC3 cells trans-
fected with AR-121 next to those cells transfected with the AR50UTRmut-AR plasmid, we
found that AR-121 ran at the same height as the lower molecular weight band, indicating that
this band is likely to be an AR-product initiating at the second translational start (Fig 3C).
AR-50UTRmutation reduces the transcriptional activity of the AR-protein
in vivo
Although we saw a markedly reduced AR protein expression in the index patient0s GF, it is
unclear whether this reduction is sufficient to abolish the transcriptional activity of the AR
hence leading to the CAIS phenotype observed in the patients. We therefore decided to test the
efficiency of the altered AR protein in the index patient0s GF in inducing endogenous target
gene transcription. While numerous endogenous AR target genes have been found in prostate
cancer derived cell lines, only three have been described in healthy male genital skin fibroblasts
[18]. Out of these, Apolipoprotein D (APOD) showed a reproducible DHT dependent tran-
scriptional induction. More recently we identified another AR-target gene in GF, the Phospha-
tidic Acid Phosphatase Type 2B (PPAP2B), and included it in this study. GF derived from male
foreskin tissue served as control. We measured mRNA levels of APOD and PPAP2B in the
presence and absence of DHT and calculated the ratio of induction. While control GF showed
a three to four fold up-regulation of APODmRNA, GF of the index patient failed to respond to
DHT as measured by APOD-induction and behaved similarly to GF obtained from a CAIS
patient with a documented AR frameshift mutation [16] (Fig 3D). Although transcriptional
induction was generally lower for PPAP2B compared to APOD, it also showed a significant
induction in response to DHT in male control GF (p<0.01) but a failure of induction in GF
derived from the index patient and the CAIS patient harboring the AR frameshift mutation
(Fig 3E). We concluded that a post-transcriptional impairment of AR protein expression is
responsible for the inability of DHT to induce a transcriptional active form of the AR in vivo
and therefore confirmed the clinical diagnosis of complete androgen insensitivity at the molec-
ular level.
The AR-50UTR uORF is translated into a polypeptide
Finally we set out to elucidate the mechanism by which the mutation alters AR protein levels.
Two not mutually exclusive scenarios can be postulated to explain the observed results. In the
first scenario, the ribosomes are stalled at the de novo ATG and therefore reach only insuffi-
ciently the AR-primary ORF (pORF). In the second option, a polypeptide is built from this
ATG. The majority of ribosomes would fall off after completion of the polypeptide and only
few would reach the AR-pORF due to leaky scanning [3]. In order to test the second option we
cloned a 6xHistidine (6xHIS)-tag in front of the putative uORF stop-codon within the AR-
50UTR and replaced the tagged uORF version (uORF-HIS) with the untagged one in the above
described AR50UTR-GFP vector. This resulted in an AR50UTRwt-HIS-GFP and an
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AR50UTRmut-HIS-GFP vector with ATG as potential uORF start codon (S3 Fig). The new
uORF of 204 nt would produce a peptide of 68 amino acids including the 6xHIS-tag and an
expected molecular weight of 8.4kDa. After transfection of both constructs in HEK293 cells, we
readily detected a polypeptide in the mutant tagged AR50UTRmut-HIS-GFP vector of the
expected molecular weight (Fig 4A) indicating usage of the newly introduced uORF by the
translational machinery. GFP expression in both constructs showed the opposite pattern in
respect to the uORF-HIS expression, evidencing that the context of the newly generated uORF
wt
mut
Fig 4. The uORF is translated into a polypeptide. Expression analysis of the HIS-tagged uORF. HEK293 cells were transfected with either
AR50UTRwtHIS-GFP or AR50UTRmutHIS-GFP. After 48h of transfection, RNA and protein was isolated. A) GFP protein analysis. Cells transfected with the
AR50UTRmutHIS-GFP construct show a strong peptide expression and highly reduced GFP protein levels. GAPDHmeasurement served as loading control.
The experiment was done in triplicate. One representative blot is displayed. B) Q-RT-PCR analysis ofGFPmRNA. There is no significant difference in the
GFPmRNA levels between the AR50UTRwtHIS-GFP and the AR50UTRmutHIS-GFP construct (p = 0.64).GFPmRNA levels were normalized to the
neomycin resistance expression of the vector. Experiments were performed in triplicate. C) Model for impaired AR-translation. In the wild type (wt) situation
the 40S ribosomal subunit scans the 50UTR for the translational start codon of the AR coding sequence (CDS). The majority of ribosomal complex will form at
the canonical AR-start codon and protein translation starts. In the mutant (mut) 50UTR a full ribosomal complex is loaded at the start of the uORF generated
though the c.-5467C>T mutation creating a polypeptide of 63 amino acids. Ribosome stalling and/or dissociation of the 60S subunit at the end of the uORF
would cause a poor re-initiation at the AR pORF. Internal ribosomal binding may lead to re-initiation at the next available ATG within a Kozak sequence to
produce a shorter (75 kD) AR protein.
doi:10.1371/journal.pone.0154158.g004
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start codon leads to the translation of a HIS-tagged polypeptide and suppresses the translation
of the consecutive GFP protein (Fig 4A). Analyzing GFPmRNA levels revealed again no differ-
ence between the AR50UTRwt-HIS-GFP and the AR50UTRmut-HIS-GFP (Fig 4B). These
results show that strong translation of the uORF encoded polypeptide within the 50UTR of the
AR is responsible for the reduced GFP and thus AR expression.
Discussion
According to the McGill Androgen Receptor Mutation Database over 500 AR gene mutations
have been identified in AIS as well as prostate cancer patients [9]. Almost all of the described
mutations are located in coding exons including splice site regions. Only three mutations
within the 5`-UTR have been reported so far in breast and prostate cancer, but none in AIS
[19, 20]. However, a functional impact of these mutations has not been analyzed.
Using NGS covering the entire AR gene locus we discovered a hitherto unrecognized muta-
tion in the 50UTR of the AR to be recurrent in AIS. We show that this mutation creates a uORF
encoded peptide, and that translation of the uORF suppresses protein expression of the pORF
without changing mRNA expression. We therefore confirm the hypothesis of Mikozami et al.
[13] who postulated in 1994 that mutations in the AR-50UTR might lead to AIS.
According to common models, uORF translation into small peptides can either cause com-
plete dissociation of the ribosomal subunits at the end of the uORF or the remaining of the 40S
ribosomal subunit on the transcript and its scanning for the next available ATG [3]. The here
presented case fits the second option because we see strong reduction but no complete inhibi-
tion of translation at the pORF (Figs 3B and 3C, 4A and 4C). One of the features affecting the
efficiency of uORF-mediated translational repression is the intercistronic distance between the
uORF and the pORF. In the case of the AR-50UTR mutation, the distance might be too small
for proper reassembly at the pORF but might enable reassembly at a further downstream ORF.
Further experiments are planned to test if different spacing between the cistrons influence
translational start site usage. In line with this, a lower molecular weight AR fragment of
approximately 75 kD appears in the index patient0s GF, possibly generated by re-initiation of
translation at an ATG downstream of the canonical AR–pORF (Figs 3B and 3C and 4C). uORF
mediated switches in translational start sites have been described in the literature [21] and
alternative start site usage has been postulated for the AR occurring at the first internal methio-
nine 191 (S1 Fig) in patients carrying an AR-stop mutation before amino acid 191 [22–24].
The resulting N-terminal deleted AR protein lacks the transactivating domain [17, 25]. An
intact N-terminus is crucial for an activating interaction between the N-and C-terminus of the
AR [26].
After DHT induction, AR full length protein in the index patient is still detectable at a low
level. Nevertheless, both patients have a complete lack of external genital virilisation. Accord-
ingly, there is no AR transcriptional activity in the patient0s GF confirming the diagnosis on a
molecular level. A possible explanation could be that the low amount of AR protein is not suffi-
cient for the development of the male phenotype during embryogenesis. Alternatively, the
shorter AR-fragment detected in the GF could act as a competitive inhibitor on AR transcrip-
tional activity because it still has a DNA-binding but no transactivation domain. In line with
this, it has been shown that the N-terminal truncated shorter AR fragment starting at methio-
nine 191 significantly reduces activity of full length AR upon DHT treatment in AR transfected
GF [27]. The fact that the lower molecular weight band is also visible in the control sample,
although much weaker compared to the full length AR, could be a consequence of leaky ribo-
some scanning at the pORF. As full length AR protein levels exceed largely those of the shorter
fragment it is unlikely to have an effect on AR-function.
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In conclusion, we provide a novel explanation for the molecular pathogenesis of AIS, one of
the most common causes of DSD. On a more general level, our results suggest that mutations
altering translational control might account for a considerable number of patients displaying
characteristic monogenic phenotypes of endocrine diseases and beyond but lacking protein
coding mutations in the associated genes to date.
Materials and Methods
Sample collection, fibroblast strains and cell culture conditions
The study was performed with approval of the Ethical Committee of the Christian-Albrechts-
University, Kiel, Germany (AZ: D415/11) (S3 File). We obtained written consent from the
parents on behalf of the children/minors enrolled in this study. Control foreskin fibroblasts
were obtained from biopsies during circumcision of males with phenotypically normal male
external genitalia. Fibroblasts from patient 1 originated from labia minora tissue which is
homologous to the male foreskin. Fibroblasts from a 46,XY CAIS individual with proven
frameshift mutation (Pro219fsX) also originated from labia minora tissue [16]. GF were grown
in phenol red free Dulbecco0s modified Eagle0s medium (Life Technologies) supplemented
with 10% fetal bovine serum (FBS; Biochrome), 100 units/ml penicillin/streptomycin, 2 mM
L-glutamine (Biochrome) and 20 mMHEPES buffer (Life Technologies) at 37°C with 5% CO2.
For hormone induction experiments, 1.2x105 cells were plated in three 6cm dishes each and
incubated at 37°C with 5% CO2. After 24h, time point zero was taken by collecting the cells in
RNA-extraction buffer (RLT; Qiagen). The remaining two dishes were washed three times in
the above medium without FBS and further grown in the same medium supplemented with
0.1% charcoal treated FBS (serum starved conditions). To the first dish DHT (Sigma-Aldrich,
Germany) dissolved in 100% ethanol was added to a final concentration of 10 nM. An equal
volume of ethanol was added to the second dish. Cells were left for 72h under these conditions
at 37°C with 5% CO2 after which they were lysed in RNA-extraction buffer (RLT; Qiagen). For
protein extractions, cells were grown in complete tissue culture medium containing 10% char-
coal treated FBS. For hormone treatment, DHT was added to a final concentration of 10nM.
Protein lysates were taken 72h after hormone treatment.
Next generation sequencing library preparation and sequencing
The sequencing library was prepared from genomic DNA of both index patients as well as con-
trols according to the Haloplex protocol (Agilent) with oligos spanning the chromosomal
region ChrX:66,754,874–66,955,461 (hg19). Sequencing was performed on a MiSeq benchtop
sequencer (Illumina). Alignment to the hg19 reference genome and single nucleotide polymor-
phism (SNP) was performed by the MiSeq-Reporter software (Illumina). Small insertion dele-
tion (indel) calling was performed using the SureCall software 3.0.1.4 from Agilent.
Sanger sequencing was performed on ABI 310 and ABI 3130 Genetic Analyzers (Applied
Biosystems) according to standard protocols.
Cloning of the 50UTR of the AR
In order to investigate the effect of the AR-5’UTR on the expression of GFP we created a modi-
fied version of the pcDNA3.1 plasmid by removing all transcribed sequences between the puta-
tive transcription start site (TSS) and the polyadenylation signal [28]. The vector was created
by PCR using primers that were able to amplify the pcDNA3.1+ backbone and concomitantly
inserted an EcoRI and a BamHI site downstream of the TSS. Two PCR fragments correspond-
ing to the 50UTR of the AR (generated from genomic DNA of a male control and of patient 1)
Androgen Receptor uORF Translation Causes Androgen Insensitivty
PLOS ONE | DOI:10.1371/journal.pone.0154158 April 25, 2016 11 / 15
and to the GFP gene were created with primers inserting an EcoRI and NcoI site to the wt and
mutant AR-5’UTR, and a NcoI and BamHI site to GFP. The two fragments were ligated into
the modified pcDNA3.1 vector and sequenced to verify the correct sequence. The uORF is out
of frame related to the GFP gene, reflecting the in vivo situation of the AR. For cloning of the
AR-5’UTR in front of the AR-CDS, we performed a PCR covering the AR-5’UTR inserting a
NsiI and BamhHI site at the very 50 end until the SexAI restriction site at the beginning of the
AR-CDS. This PCR product was cut with NsiI and SexAI and cloned into a NsiI/ SexAI cut
psvARO vector [17]. A BamHI fragment covering the entire AR-50UTR and -CDS was then
cloned into the above pcDNA3.1 derived vector and sequenced for verification. For the HIS
tagged uORF an overlap extension PCR was performed in order to insert six histidines in front
of the uORF stop codon in both the wt and mut AR-50UTR. The HIS-tagged uORF containing
AR-50UTR was then cloned in the modified pcDNA3.1 vector and sequenced as described
above. A schematic representation of the in vitro constructs is shown in S3 Fig. Primers used
for cloning are listed in S1 Table.
Transfection experiments
HEK293T cells were grown in DMEM supplemented with 10% FBS. Typically 400,000 cells
were plated in each well of a 6 well plate and transfected the day after using 1 μg of plasmid
DNA/well and lipofectamine 2000 (Life Technologies). After 72h of transfection, cells were col-
lected for concomitant protein and RNA extraction using the PARIS kit (Life Technologies)
and for FACS analysis by resuspending the cells in phosphate buffered saline (PBS) supple-
mented with 2% FBS. For luciferase experiments 200,000 HEK293T cells were transfected with
10 ng of either AR50UTRwt-AR vector, AR50UTRmut-AR vector or empty vector together with
80 ng Renilla-luciferase vector as well as 400 ng of the ARE-luciferase reporter vector. The next
day, DHT was added to the cells at a final concentration of 10 nM in order to activate the AR-
protein. After further 24h, Firefly luciferase and Renilla luciferase expressions were measured
according to the Dual-Luciferase Reporter Assay protocol (Promega) using a Veritas micro-
plate luminometer (Turner BioSystems). PC3 cells were grown in RPMI supplemented with
10% FBS. Typically 200,000 cells were plated in each well of a 6 well plate and transfected the
day after using 2 μg of plasmid DNA/well and lipofectamine 2000 (Life Technologies). The
next day, cells were washed twice in RPMI without FBS and then incubated in RPMI supple-
mented with charcoal treated FBS containing either 10nM DHT or 100% ethanol for 24 hours.
Cells were lysed in RIPA buffer for protein extraction.
FACS analysis
Roughly 1x105 cells were resuspended in FACS buffer (PBS, 2% FBS). Flow cytometry data
were acquired on a BD Accuri C6 (BD Biosciences) and analyzed with the BDCSampler soft-
ware (BD Biosciences).
RNA isolation, amplification and detection
Total RNA was isolated from fibroblasts using the RNeasy kit (Qiagen). 500ng of total RNA
was reverse transcribed using the QuantiTect Reverse Transcription Kit (Qiagen). Quantitative
PCR was performed with the QuantiTect SYBR Green master mix (Qiagen) using primers
against APOD, AR and SDHA. All primers were purchased from Qiagen and used following
the manufacturer0s instructions. For HEK293T transfections, 500ng RNA extracted using the
PARIS kit (Life Technologies) was treated twice with TURBO DNase (Life Technologies) to
eliminate residual plasmid DNA and reverse transcribed using the QuantiTect Reverse Tran-
scription Kit (Qiagen). The reverse transcription reaction was also performed in the absence of
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Reverse Transcriptase. Quantitative PCR was performed with the QuantiTect SYBR Green
master mix (Qiagen) using primers against the AR-50UTR and GFP (S1 Table) and the neomy-
cin resistance gene (neo) [29]. Primer were designed using the Primer3 software. p-values were
calculated using a two-sided t-test.
Protein isolation and detection
Whole cell protein lysates were obtained by resuspending the cells in ice-cold RIPA buffer, sup-
plemented with a cocktail of protease inhibitors (CompleteTM, Roche). Protein extracts were
separated by SDS-PAGE on a NuPAGE1 Novex1 4–12% Bis-Tris Protein gel (Life Technolo-
gies) and transferred to a nitrocellulose membrane (Whatman, GE Healtehcare Life Sciences).
The membrane was blocked for 1-2h at room temperature with TBS containing 0.1% Tween
and 5% non-fat dry milk. For AR and HIS detection F39.4.1 antibody (BioGenex) (1:100 dilu-
tion) and Anti-6xHIS tag antibody (Anti-HIS HRP, MACS) (1:10,000 dilution) was used
respectively over night at 4°C, for actin detection Anti-Actin (A 2066) antibody (Sigma-
Aldrich) was used for 1-2h at room temperature (1:10,000 dilution). Anti-GFP-HRP (MACS)
was used for the duration of 1h at room temperature for GFP detection (1:5,000 dilution) and
GAPDH antibody (GeneTex) was used for 45min at room temperature (1:10,000 dilution) for
GAPDH detection. Secondary anti-rabbit and anti-mouse antibodies (Immuno Reagents Inc.)
were incubated for 1-2h at room temperature (1:4,000 dilution). All antibodies were resus-
pended in TBS containing 0.1% Tween and 5% non-fat dry milk. Signals were detected on an
Amersham Hyperfilm ECL (GE Healthcare) using the Luminata Forte Western HRP Substrate
(Millipore). Expected molecular weights of polypeptides were calculated using EMBOSS GUI
v.1.14: pepstats.
Supporting Information
S1 Fig. Kozak sequences around the start codon of the uORF, pORF and the downstream
ORF starting at amino acid 191 of the AR. The depicted Kozak consensus sequence is a
sequence occurring on eukaryotic mRNA. Big letters correspond to high evolutionary conser-
vation.
(PDF)
S2 Fig. PCR analysis of GFP and neomycin resistance mRNA after DNAse treatment.
HEK293 cells were transfected with either empty vector, AR50-UTRwt-GFP, AR50-UTRmut-
GFP or not transfected at all. After 72h of transfection, RNA was isolated and treated with
DNAse in order to completely digest vector DNA. The expected size for neo is 95bp, that of
GFP is 201bp. The minus reverse transcriptase control (-RT) shows no PCR-product, demon-
strating that plasmid-DNA was completely digested from the samples.
(PDF)
S3 Fig. Schematic representation of the constructs used for the in vitro studies.
(PDF)
S1 File. List of SNPs found in patient 1.
(XLSX)
S2 File. List if SNPs found in patient 2.
(XLSX)
S3 File. Study approval by the Ethical Committee of the Christian-Albrechts-University,
Kiel, Germany.
(PDF)
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